☆ 4.7 Review

Type 2 Diabetes Mellitus and Liver Disease: Across the Gut-Liver Axis from Fibrosis to Cancer

NUTRIENTS (2023)

Related references

Note: Only part of the references are listed.

Review Biochemistry & Molecular Biology

The Gut-Vascular Barrier as a New Protagonist in Intestinal and Extraintestinal Diseases

Natalia Di Tommaso et al.

Summary: The intestinal barrier is the first line of defense between the outside world and the intestine, and disruption can lead to increased intestinal permeability, causing intestinal and extra-intestinal diseases. The identification of a gut-vascular barrier has provided new evidence for the etiology and management of gut-liver axis and gut-brain axis diseases, with recent implications in oncology as well. The gut-brain axis is involved in neuroinflammatory processes, and the recent description of a choroid plexus vascular barrier regulating brain permeability under gut inflammation conditions identifies the endothelium as a key regulator in maintaining tissue homeostasis and health.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Article Gastroenterology & Hepatology

A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes

Veeral Ajmera et al.

Summary: This study evaluated the prevalence of advanced fibrosis and cirrhosis in patients with T2DM, and found that the prevalence of fibrosis was 14% and cirrhosis was 6%. These results highlight the high risk of advanced fibrosis/cirrhosis in T2DM patients aged >-50 years.

JOURNAL OF HEPATOLOGY (2023)

Add to Collection

Review Biochemistry & Molecular Biology

The intestinal immune system and gut barrier function in obesity and ageing

Sarah J. Shemtov et al.

Summary: Obesity and ageing are associated with an increased risk of chronic diseases, including metabolic abnormalities and chronic inflammation. The intestine plays a crucial role in promoting chronic tissue inflammation, and abnormalities in the intestinal mucosal barrier are linked to various inflammatory conditions. The intestinal immune system and barrier function have significant impacts on the pathogenesis of obesity and age-related diseases.

FEBS JOURNAL (2023)

Add to Collection

Review Microbiology

Endotoxemia and Gastrointestinal Cancers: Insight into the Mechanisms Underlying a Dangerous Relationship

Vittoria Manilla et al.

Summary: Lipopolysaccharide (LPS), a component of gram-negative bacteria, is a recognized marker of sepsis. Disruption of the intestinal barrier leads to translocation of LPS into the bloodstream, triggering an inflammatory response and immune dysregulation. This is a critical step in the exacerbation of diseases, including metabolic disorders and cancer. This review explores the mechanisms linking endotoxemia to tumorigenesis and possible therapeutic interventions.

MICROORGANISMS (2023)

Add to Collection

Review Chemistry, Applied

Research advances of advanced glycation end products in milk and dairy products: Formation, determination, control strategy and immunometabolism via gut microbiota

Lezhen Dong et al.

Summary: This article systematically discusses the content, influencing factors, inhibition mechanism and levels of advanced glycosylation end products (AGEs) in milk and dairy products under different processing conditions. Different processing techniques have a significant effect on AGEs content, and the article also explores the impact of gut microbiota on AGEs metabolism. The research provides suggestions for AGEs mitigation strategies to optimize dairy production.

FOOD CHEMISTRY (2023)

Add to Collection

Review Endocrinology & Metabolism

The Metabolic Role and Therapeutic Potential of the Microbiome

Louise E. Olofsson et al.

Summary: This article discusses the alterations and contributions of gut bacterial composition in cardiometabolic diseases. The research has focused on identifying associations between the gut microbiota and human disease states, and exploring the potential mechanisms and causality. The study also highlights the role of microbially produced metabolites and molecules in modulating cardiometabolic diseases.

ENDOCRINE REVIEWS (2022)

Add to Collection

Review Gastroenterology & Hepatology

The Neglected Role of Bile Duct Epithelial Cells in NASH

Massimiliano Cadamuro et al.

Summary: NAFLD is the most common liver disease worldwide, linked to metabolic syndrome and insulin resistance. NASH is a severe form of NAFLD that may progress to cirrhosis and liver cancer. Research aims to investigate the effects of adipokines and metabolic alterations on cholangiocytes to understand the mechanisms driven by insulin resistance in NASH.

SEMINARS IN LIVER DISEASE (2022)

Add to Collection

Article Gastroenterology & Hepatology

TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models

Miriam Longo et al.

Summary: The study found that the co-presence of 3 at-risk variants, PNPLA3, TM6SF2, and MBOAT7, has a significant impact on the course of NAFLD in both patients and experimental models. It affects liver disease severity, LD accumulation, mitochondrial functionality, and metabolic reprogramming, leading to an increased risk of HCC.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2022)

Add to Collection

Review Food Science & Technology

Dietary polyphenols: regulate the advanced glycation end products-RAGE axis and the microbiota-gut-brain axis to prevent neurodegenerative diseases

Yueqin Li et al.

Summary: Advanced glycation end products (AGEs) are formed in the reaction between reducing sugars and amino acids, and play a key role in neurodegenerative diseases. Polyphenols with multiple hydroxyl groups can inhibit the formation of AGEs and prevent neurodegenerative diseases. Regulating gut microbiota and intestinal inflammation is also a strategy for preventing neurodegenerative diseases.

CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives

Mariyam Khalid et al.

Summary: Persistent hyperglycemia in type 2 diabetes mellitus triggers a glycation reaction, resulting in the formation of AGEs. Binding of AGEs with its receptor RAGE activates various signaling pathways, leading to oxidative stress, inflammation, compromised insulin signaling, metabolic disturbances, pancreatic beta cell toxicity, and epigenetic modifications. This review summarizes the sources of AGEs, their role in metabolic dysfunction, and the AGEs/RAGE signaling cascade in type 2 diabetes mellitus and its associated complications.

BIOMOLECULES (2022)

Add to Collection

Review Immunology

The Crosstalk Between Liver Sinusoidal Endothelial Cells and Hepatic Microenvironment in NASH Related Liver Fibrosis

Wei Du et al.

Summary: This article reviews the key role of crosstalk between liver sinusoidal endothelial cells (LSECs) and hepatic microenvironment in the progression of NASH to liver fibrosis, and discusses promising therapeutic strategies targeting LSECs.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Review Gastroenterology & Hepatology

Portal Hypertension in Nonalcoholic Fatty Liver Disease: From Pathogenesis to Clinical Practice

Saut Horas H. Nababan et al.

Summary: Portal hypertension may occur early in nonalcoholic fatty liver disease (NAFLD) due to hepatocellular lipid accumulation and dysfunction. Insulin resistance and gut dysbiosis may also contribute to this process. However, the clinical impact of early portal hypertension in NAFLD remains uncertain.

JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2022)

Add to Collection

Article Multidisciplinary Sciences

Mangrove fruit (Bruguiera gymnorhiza) increases circulating GLP-1 and PYY, modulates lipid profiles, and reduces systemic inflammation by improving SCFA levels in obese wistar rats

Rinta Amalia et al.

Summary: Bruguiera gymnorhiza fruit flour (BGF) has the potential to be used as a functional food due to its ability to increase satiety hormones, reduce lipid levels, and decrease systemic inflammation in diet-induced obese rats.

HELIYON (2022)

Add to Collection

Review Gastroenterology & Hepatology

Portal Hypertension in Nonalcoholic Fatty Liver Disease: From Pathogenesis to Clinical Practice

Saut Horas H. Nababan et al.

Summary: Portal hypertension in nonalcoholic fatty liver disease (NAFLD) typically occurs in the cirrhotic stage, but evidence suggests that it can also develop in early stages of NAFLD, possibly due to hepatocellular lipid accumulation and dysfunction. This early portal hypertension may be associated with increased intrahepatic vascular resistance and external factors such as insulin resistance and gut dysbiosis. Tools for diagnosis and monitoring of portal hypertension in NAFLD are being studied to identify high-risk patients and guide therapy.

JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2022)

Add to Collection

Article Gastroenterology & Hepatology

Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis

Susanne Gaul et al.

Summary: The study found that hepatocyte pyroptosis, caused by NLRP3 inflammasome activation, leads to the release of inflammasome proteins and exacerbates fibrogenesis. Inhibition of caspase-1 and gasdermin D activation can prevent pyroptosis. The released inflammasomes are taken up by hepatic stellate cells, promoting inflammation and fibrosis. These findings suggest a novel mechanism for liver injury and potential therapeutic targets for chronic liver diseases.

JOURNAL OF HEPATOLOGY (2021)

Add to Collection

Review Endocrinology & Metabolism

Association of Diabetes Mellitus and Cholangiocarcinoma: Update of Evidence and the Effects of Antidiabetic Medication

Charupong Saengboonmee et al.

Summary: Diabetes mellitus is a risk factor for cancer and is associated with an increased risk of cholangiocarcinoma. The antidiabetic drug metformin is associated with a reduced risk of cholangiocarcinoma and inhibited progression. Different antidiabetic medications have varying effects on the development and progression of cholangiocarcinoma.

CANADIAN JOURNAL OF DIABETES (2021)

Add to Collection

Article Cell Biology

Adipose tissue inflammation and metabolic dysfunction in obesity

Tatsuo Kawai et al.

Summary: Chronic low-grade inflammation of adipose tissue is linked to metabolic disease and organ complications, mainly caused by the secretion of inflammatory substances by adipocytes and infiltration of immune cells. Despite being low-grade, this inflammation negatively impacts remote organ function and is considered a causative factor of obesity-related complications.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2021)

Add to Collection

Article Endocrinology & Metabolism

High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among US Adults With Type 2 Diabetes

Stefano Ciardullo et al.

Summary: The prevalence of liver steatosis and fibrosis is high in patients with T2DM from the United States, with obesity being a major risk factor. Screening for these conditions among patients with diabetes is recommended based on the study results.

DIABETES CARE (2021)

Add to Collection

Article Endocrinology & Metabolism

Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening

Romina Lomonaco et al.

Summary: This study assessed the prevalence of NAFLD and liver fibrosis in patients with type 2 diabetes mellitus, revealing that at least 15% of patients with T2DM and NAFLD have moderate-to-advanced fibrosis. Screening for liver disease can be enhanced using imaging and plasma diagnostic panels, as AST/ALT alone are inadequate as initial screening markers.

DIABETES CARE (2021)

Add to Collection

Article Endocrinology & Metabolism

Intestine-liver crosstalk in Type 2 Diabetes and non-alcoholic fatty liver disease

Margaux Nawrot et al.

Summary: Type 2 diabetes and Non-Alcoholic Fatty Liver Disease are influenced by the interaction between the intestine and the liver, particularly through changes in gut microbiota and intestinal permeability. Targeting intestinal functions may be a promising therapeutic approach for these metabolic diseases.

METABOLISM-CLINICAL AND EXPERIMENTAL (2021)

Add to Collection

Review Gastroenterology & Hepatology

Role of liver sinusoidal endothelial cells in liver diseases

Jordi Gracia-Sancho et al.

Summary: Liver sinusoidal endothelial cells (LSECs) play crucial roles in hepatic homeostasis, being involved in regulation of vascular tone, inflammation, and thrombosis, as well as control of the hepatic immune response. Dysregulations of LSECs in the context of liver disease and hepatocellular carcinoma make them potential therapeutic targets.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Add to Collection

Article Genetics & Heredity

Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and India

Camila Alvarez-Silva et al.

Summary: This study compared the gut microbiota of Danish and South Indian individuals, identifying microbial signatures of T2D and metformin treatment. Both Danish and Indian T2D patients showed microbial changes, while metformin treatment led to a trans-ethnic microbial signature.

GENOME MEDICINE (2021)

Add to Collection

Review Cell Biology

NLRP3 Inflammasome at the Interface of Inflammation, Endothelial Dysfunction, and Type 2 Diabetes

Ilona M. Gora et al.

Summary: Type 2 diabetes mellitus is characterized by chronic inflammation, and the activation of the NLRP3 inflammasome plays a significant role in this condition. Endothelial dysfunction is identified as a key step in inflammasome activation, suggesting that targeting the NLRP3 inflammasome could offer new therapeutic approaches.

CELLS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

GLP-1 reduces the migration of hepatocellular carcinoma cells via suppression of the stress-activated protein kinase/c-Jun N-terminal kinase pathway

Noriko Yamada et al.

Summary: In this study, it was observed that GLP-1 can suppress the migration of HCC cells induced by TGF-? and HGF by inhibiting the SAPK/JNK signaling pathway, and this inhibition is mediated by cAMP production.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Slimy partners: the mucus barrier and gut microbiome in ulcerative colitis

Jian Fang et al.

Summary: By reviewing the interactions between gut microbiome and the mucus layer, this article sheds light on the potential for developing new treatments for ulcerative colitis (UC). Understanding the bidirectional communication between the gut microbiota and the colon's mucus layer is crucial in addressing the imbalance that leads to UC. The mucus layers play a key role in nourishing 'good' microbes while excluding pathogens, and disruptions in this balance may result in inflammatory bowel diseases.

EXPERIMENTAL AND MOLECULAR MEDICINE (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC

Hyunmi Kim et al.

Summary: Liver disease encompasses a spectrum of liver damage from simple steatosis to hepatocellular carcinoma, with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes often coexisting. Despite the lack of suitable drugs for NAFLD and NASH, thiazolidinediones drugs are sometimes used to improve liver failure.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Review Oncology

The Hepatic Sinusoid in Chronic Liver Disease: The Optimal Milieu for Cancer

Albert Gibert-Ramos et al.

Summary: This article discusses how the dysregulation of hepatic sinusoidal cells during chronic liver disease may play a role in the development of hepatocellular carcinoma, and potential treatments that may affect this process. After injury, the disruption of sinusoidal communication can potentially affect the overall liver function.

CANCERS (2021)

Add to Collection

Article Medicine, General & Internal

A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis

Philip N. Newsome et al.

Summary: This phase 2 trial demonstrated that treatment with semaglutide resulted in a significantly higher percentage of patients with NASH resolution compared to placebo in patients with NASH, but did not show a significant between-group difference in the percentage of patients with an improvement in fibrosis stage.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Review Cell Biology

Gut Microbiota and Type 2 Diabetes Mellitus: Association, Mechanism, and Translational Applications

Lili Zhang et al.

Summary: The gut microbiota plays a crucial role in type 2 diabetes by regulating inflammation, immunity, and metabolism, with molecules like short-chain fatty acids, secondary bile acids, and lipopolysaccharide being key factors. Studies have shown that fecal microbiota transplantation and probiotic capsules are useful strategies in preventing diabetes.

MEDIATORS OF INFLAMMATION (2021)

Add to Collection

Review Oncology

Mitochondrial Dynamics and Liver Cancer

Maria Isabel Hernandez-Alvarez et al.

Summary: Hepatocellular carcinoma is a major cause of cancer-related deaths globally, with risk factors including viral infections, autoimmune hepatitis, diabetes, and alcohol abuse. Current therapies have limited efficacy, highlighting the need for novel treatment strategies. Emerging data suggest that mitochondrial dynamics may play a role in the development of liver tumors.

CANCERS (2021)

Add to Collection

Article Medicine, General & Internal

Association of Insulin Resistance and Type 2 Diabetes With Gut Microbial Diversity A Microbiome-Wide Analysis From Population Studies

Zhangling Chen et al.

Summary: This study found that higher microbiome alpha diversity, as well as more butyrate-producing gut bacteria, were associated with lower incidence of type 2 diabetes and reduced levels of insulin resistance in individuals without diabetes, providing insights into the etiology, pathogenesis, and potential treatment of type 2 diabetes.

JAMA NETWORK OPEN (2021)

Add to Collection

Article Oncology

TLR2 inhibition ameliorates the amplification effect of LPS on lipid accumulation and lipotoxicity in hepatic cells

Liting Zhang et al.

Summary: The study revealed that TLR2 played a role in lipid accumulation and lipotoxicity in the PA-induced NAFLD cell model, which were aggravated by LPS. Inhibition of TLR2 significantly ameliorated these effects, while LPS alone had no significant impact on L02 cells.

ANNALS OF TRANSLATIONAL MEDICINE (2021)

Add to Collection

Review Gastroenterology & Hepatology

Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis

Oliver Clements et al.

JOURNAL OF HEPATOLOGY (2020)

Add to Collection

Review Gastroenterology & Hepatology

Systematic review: chronic viral hepatitis and metabolic derangement

Chia-Chi Wang et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)

Add to Collection

Article Gastroenterology & Hepatology

Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease

Fasiha Kanwal et al.

HEPATOLOGY (2020)

Add to Collection

Review Medicine, General & Internal

Nonalcoholic Fatty Liver Disease: What Does the Primary Care Physician Need to Know?

Jeffrey Budd et al.

AMERICAN JOURNAL OF MEDICINE (2020)

Add to Collection

Review Gastroenterology & Hepatology

Update on NAFLD genetics: From new variants to the clinic

Eric Trepo et al.

JOURNAL OF HEPATOLOGY (2020)

Add to Collection

Review Immunology

The Interplay Between Tissue Niche and Macrophage Cellular Metabolism in Obesity

Sabine Daemen et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping

Zhipeng Liu et al.

JOURNAL OF HEPATOLOGY (2020)

Add to Collection

Review Cell Biology

Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives

Natascha Roehlen et al.

CELLS (2020)

Add to Collection

Review Pharmacology & Pharmacy

Microbiota-derived butyrate regulates intestinal inflammation: Focus on inflammatory bowel disease

Mafalda R. Couto et al.

PHARMACOLOGICAL RESEARCH (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Glucagon-Like Peptide-1 Receptor Agonist Prevented the Progression of Hepatocellular Carcinoma in a Mouse Model of Nonalcoholic Steatohepatitis

Motoyasu Kojima et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Article Multidisciplinary Sciences

JNK-mediated disruption of bile acid homeostasis promotes intrahepatic cholangiocarcinoma

Elisa Manieri et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Add to Collection

Article Oncology

Diabetes and PKM2 affect prognosis in patients with intrahepatic cholangiocarcinoma

Kui Fu et al.

ONCOLOGY LETTERS (2020)

Add to Collection

Article Immunology

Short-Chain Fatty Acids: A Soldier Fighting Against Inflammation and Protecting From Tumorigenesis in People With Diabetes

Qiyu Yang et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease

Francesca Romana Ponziani et al.

HEPATOLOGY (2019)

Add to Collection

Review Gastroenterology & Hepatology

Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

Zobair Younossi et al.

HEPATOLOGY (2019)

Add to Collection

Article Biotechnology & Applied Microbiology

Pyruvate kinase L/R is a regulator of lipid metabolism and mitochondrial function

Zhengtao Liu et al.

METABOLIC ENGINEERING (2019)

Add to Collection

Article Genetics & Heredity

Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases

Serena Sanna et al.

NATURE GENETICS (2019)

Add to Collection

Article Medicine, General & Internal

Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts

Myriam Alexander et al.

BMC MEDICINE (2019)

Add to Collection

Review Endocrinology & Metabolism

Bile acids in glucose metabolism and insulin signalling - mechanisms and research needs

Tiara R. Ahmad et al.

NATURE REVIEWS ENDOCRINOLOGY (2019)

Add to Collection

Review Biochemistry & Molecular Biology

Mitochondrial Dysfunction in the Transition from NASH to HCC

Melissa Leveille et al.

METABOLITES (2019)

Add to Collection

Review Gastroenterology & Hepatology

Hepatic microcirculation and mechanisms of portal hypertension

Jordi Gracia-Sancho et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)

Add to Collection

Article Nutrition & Dietetics

Contribution of the gut microbiota to the regulation of host metabolism and energy balance: a focus on the gut-liver axis

N. M. Delzenne et al.

PROCEEDINGS OF THE NUTRITION SOCIETY (2019)

Add to Collection

Review Immunology

Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases

Daniela Parada Venegas et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives

Sotirios Tsalamandris et al.

EUROPEAN CARDIOLOGY REVIEW (2019)

Add to Collection

Review Gastroenterology & Hepatology

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

Zobair Younossi et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)

Add to Collection

Article Gastroenterology & Hepatology

Clinical and metabolic effects associated with weight changes and obeticholic acid in non-alcoholic steatohepatitis

B. Hameed et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)

Add to Collection

Article Cell Biology

Lactobacillus gasseri in the Upper Small Intestine Impacts an ACSL3-Dependent Fatty Acid-Sensing Pathway Regulating Whole-Body Glucose Homeostasis

Paige V. Bauer et al.

CELL METABOLISM (2018)

Add to Collection

Editorial Material Cell Biology

Hold the Door: Role of the Gut Barrier in Diabetes

Anthony Martin et al.

CELL METABOLISM (2018)

Add to Collection

Review Biochemistry & Molecular Biology

Insulin-Like Growth Factor (IGF) System in Liver Diseases

Agnieszka Adamek et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Add to Collection

Review Medicine, Research & Experimental

Gastrointestinal complications in patients with diabetes mellitus

Agnieszka E. Zawada et al.

ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2018)

Add to Collection

Review Gastroenterology & Hepatology

Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases

Jonathan G. Stine et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)

Add to Collection

Review Cardiac & Cardiovascular Systems

Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies

Raminderjit Kaur et al.

CARDIOVASCULAR DIABETOLOGY (2018)

Add to Collection

Review Biochemistry & Molecular Biology

The PI3K/AKT pathway in obesity and type 2 diabetes

Xingjun Huang et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)

Add to Collection

Review Gastroenterology & Hepatology

Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis

Simona Leoni et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2018)

Add to Collection

Review Oncology

Cancer as a Matter of Fat: The Crosstalk between Adipose Tissue and Tumors

Ernst Lengyel et al.

TRENDS IN CANCER (2018)

Add to Collection

Article Gastroenterology & Hepatology

Histological Severity and Clinical Outcomes of Nonalcoholic Fatty Liver Disease in Nonobese Patients

Jonathan Chung-Fai Leung et al.

HEPATOLOGY (2017)

Add to Collection

Review Gastroenterology & Hepatology

Bile Acids and Nonalcoholic Fatty Liver Disease: Molecular Insights and Therapeutic Perspectives

Juan P. Arab et al.

HEPATOLOGY (2017)

Add to Collection

Review Endocrinology & Metabolism

Metabolic endotoxemia and diabetes mellitus: A systematic review

Junia Maria Geraldo Gomes et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2017)

Add to Collection

Article Multidisciplinary Sciences

Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease

Evelyn Nunes Goulart da Silva Pereira et al.

PLOS ONE (2017)

Add to Collection

Review Immunology

Type 1 Diabetes: A Chronic Anti-Self-Inflammatory Response

Matthew Clark et al.

FRONTIERS IN IMMUNOLOGY (2017)

Add to Collection

Review Endocrinology & Metabolism

Diabetic hepatosclerosis: True clinical entity or ghost disease?

Natalia G. Vallianou et al.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2017)

Add to Collection

Review Oncology

Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease

Alessandro Mantovani et al.

ANNALS OF TRANSLATIONAL MEDICINE (2017)

Add to Collection

Article Gastroenterology & Hepatology

Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis

Ju Dong Yang et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)

Add to Collection

Article Biochemistry & Molecular Biology

GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway

Qin He et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)

Add to Collection

Article Gastroenterology & Hepatology

Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease

Sahil Mittal et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)

Add to Collection

Article Endocrinology & Metabolism

Diabetic hepatosclerosis: another diabetes microvascular complication?

R. J. King et al.

DIABETIC MEDICINE (2016)

Add to Collection

Article Gastroenterology & Hepatology

IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models

Iris Martinez-Quetglas et al.

GASTROENTEROLOGY (2016)

Add to Collection

Article Gastroenterology & Hepatology

Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes

Zobair M. Younossi et al.

HEPATOLOGY (2016)

Add to Collection

Review Gastroenterology & Hepatology

Sinusoidal communication in liver fibrosis and regeneration

Giusi Marrone et al.

JOURNAL OF HEPATOLOGY (2016)

Add to Collection

Review Gastroenterology & Hepatology

Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?

Luca Valenti et al.

LIVER INTERNATIONAL (2016)

Add to Collection

Article Multidisciplinary Sciences

Human gut microbes impact host serum metabolome and insulin sensitivity

Helle Krogh Pedersen et al.

NATURE (2016)

Add to Collection

Review Endocrinology & Metabolism

Gut microbiota and immune crosstalk in metabolic disease

Remy Burcelin

MOLECULAR METABOLISM (2016)

Add to Collection

Article Oncology

Outcomes of Hepatic Resection in Intrahepatic Cholangiocarcinoma Patients with Diabetes, Hypertension, and Dyslipidemia: Significance of Routine Follow-Up

Takayoshi Nishioka et al.

LIVER CANCER (2016)

Add to Collection

Review Cell Biology

Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?

Mohamed Asrih et al.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)

Add to Collection

Article Multidisciplinary Sciences

A gut-vascular barrier controls the systemic dissemination of bacteria

Ilaria Spadoni et al.

SCIENCE (2015)

Add to Collection

Article Cell Biology

The PPARα-FGF21 Hormone Axis Contributes to Metabolic Regulation by the Hepatic JNK Signaling Pathway

Santiago Vernia et al.

CELL METABOLISM (2014)

Add to Collection

Article Gastroenterology & Hepatology

Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team

Jessica Dyson et al.

JOURNAL OF HEPATOLOGY (2014)

Add to Collection

Review Cell Biology

Toll-like receptor 2/4 links to free fatty acid-induced inflammation and β-cell dysfunction

Jiajing Yin et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2014)

Add to Collection

Article Multidisciplinary Sciences

The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes

Rachel J. Perry et al.

NATURE (2014)

Add to Collection

Article Oncology

LPS promotes epithelial-mesenchymal transition and activation of TLR4/JNK signaling

Hangyu Li et al.

TUMOR BIOLOGY (2014)

Add to Collection

Article Gastroenterology & Hepatology

Toll-Like Receptor 2 and Palmitic Acid Cooperatively Contribute to the Development of Nonalcoholic Steatohepatitis Through Inflammasome Activation in Mice

Kouichi Miura et al.

HEPATOLOGY (2013)

Add to Collection

Article Multidisciplinary Sciences

Gut metagenome in European women with normal, impaired and diabetic glucose control

Fredrik H. Karlsson et al.

NATURE (2013)

Add to Collection

Review Gastroenterology & Hepatology

NAFLD, NASH and liver cancer

Gregory A. Michelotti et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)

Add to Collection

Article Multidisciplinary Sciences

Anti-Obesity Effect of Lactobacillus gasseri BNR17 in High-Sucrose Diet-Induced Obese Mice

Ji-Hee Kang et al.

PLOS ONE (2013)

Add to Collection

Review Gastroenterology & Hepatology

PNPLA3 I148M polymorphism and progressive liver disease

Paola Dongiovanni et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2013)

Add to Collection

Review Gastroenterology & Hepatology

Branched-chain amino acids in liver diseases

Kazuto Tajiri et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2013)

Add to Collection

Review Endocrinology & Metabolism

A Twenty-First Century Cancer Epidemic Caused by Obesity: The Involvement of Insulin, Diabetes, and Insulin-Like Growth Factors

Rosalyne L. Westley et al.

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2013)

Add to Collection

Article Biochemistry & Molecular Biology

Adiponectin: Key Player in the Adipose Tissue-Liver Crosstalk

A. R. Moschen et al.

CURRENT MEDICINAL CHEMISTRY (2012)

Add to Collection

Article Gastroenterology & Hepatology

Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease

Romina Lomonaco et al.

HEPATOLOGY (2012)

Add to Collection

Article Medicine, General & Internal

Nonalcoholic Fatty Liver Disease in Lean Individuals in the United States

Zobair M. Younossi et al.

MEDICINE (2012)

Add to Collection

Article Gastroenterology & Hepatology

The prevalence and clinical characteristics of glucose metabolism disorders in patients with liver cirrhosis. A prospective study

Diego Garcia-Compean et al.

ANNALS OF HEPATOLOGY (2012)

Add to Collection

Article Gastroenterology & Hepatology

Insulin resistance and liver microcirculation in a rat model of early NAFLD

Marcos Pasarin et al.

JOURNAL OF HEPATOLOGY (2011)

Add to Collection

Article Gastroenterology & Hepatology

Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity

Anna Ludovica Fracanzani et al.

JOURNAL OF HEPATOLOGY (2011)

Add to Collection

Article Gastroenterology & Hepatology

Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors

Nathalie C. Leite et al.

LIVER INTERNATIONAL (2011)

Add to Collection

Review Gastroenterology & Hepatology

NF-κB in the liver-linking injury, fibrosis and hepatocellular carcinoma

Tom Luedde et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)

Add to Collection

Article Endocrinology & Metabolism

Toll-like receptor 2-deficient mice are protected from insulin resistance and beta cell dysfunction induced by a high-fat diet

J. A. Ehses et al.

DIABETOLOGIA (2010)

Add to Collection

Article Gastroenterology & Hepatology

Non-alcoholic steatohepatitis induces non-fibrosis-related portal hypertension associated with splanchnic vasodilation and signs of a hyperdynamic circulation in vitro and in vivo in a rat model

Sven Francque et al.

LIVER INTERNATIONAL (2010)

Add to Collection

Article Gastroenterology & Hepatology

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes

Anna Ludovica Fracanzani et al.

HEPATOLOGY (2008)

Add to Collection

Editorial Material Gastroenterology & Hepatology

Hepatic steatosis: A benign disease or a silent killer

Abdel-Rahman El-Zayadi

WORLD JOURNAL OF GASTROENTEROLOGY (2008)

Add to Collection

Article Endocrinology & Metabolism

Metabolic endotoxemia initiates obesity and insulin resistance

Patrice D. Cani et al.

DIABETES (2007)

Add to Collection

Article Endocrinology & Metabolism

Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes

S. J. Creely et al.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)

Add to Collection

Article Endocrinology & Metabolism

Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms

E Bugianesi et al.

DIABETOLOGIA (2005)

Add to Collection

Article Multidisciplinary Sciences

The gut microbiota as an environmental factor that regulates fat storage

F Bäckhed et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Add to Collection

Article Medicine, General & Internal

Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults

HJ Kim et al.

ARCHIVES OF INTERNAL MEDICINE (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.